Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

DRI Healthcare Trust (T:DHT.UN)

Business Focus: N/A

May 07, 2024 12:18 pm ET
DRI Healthcare Trust Announces Voting Results of AGM
TORONTO, May 7, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 7, 2024. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 26, 2024 were elected to serve as trustees for the ensuing year, and Deloitte LLP was reappointed as auditors of the Trust.
May 06, 2024 05:00 pm ET
DRI Healthcare Trust Reports First Quarter 2024 Results
– Highest quarterly Adjusted EBITDA since IPO underscores continued execution of growth strategy – 
Apr 23, 2024 05:31 pm ET
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
– Transaction significantly reduces potential dilution with a net reduction of warrants equivalent to 8.2% of units outstanding –
Apr 16, 2024 10:00 am ET
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 7, 2024
TORONTO, April 16, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its first quarter 2024 financial results on Tuesday, May 7, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Monday, May 6, 2024, after market close.
Apr 15, 2024 07:00 am ET
DRI Healthcare Trust Announces Refinancing of Preferred Securities
– Transaction reduces the Trust's potential unit dilution by 8.2% by retiring in-the-money warrants and replacing them with out-of-the-money warrants –
Mar 26, 2024 10:30 am ET
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, March 26, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) ( TSX: DHT.U) ("DRI" or the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that the Trust will participate in the following investor conferences in April and May:
Feb 28, 2024 04:00 pm ET
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results
– 82% royalty income growth over prior year period underscores transformative year –
Feb 08, 2024 09:30 am ET
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024
TORONTO, Feb. 8, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Wednesday, February 28, 2024, after market close.
Feb 01, 2024 08:59 am ET
Canadian Investment Regulatory Organization Trade Resumption - DHT.UN
TORONTO, Feb. 1, 2024 /CNW/ - Trading resumes in:
Feb 01, 2024 08:49 am ET
Canadian Investment Regulatory Organization Trading Halt - DHT.UN
TORONTO, Feb. 1, 2024 /CNW/ - The following issues have been halted by CIRO:
Feb 01, 2024 08:31 am ET
Dec 20, 2023 04:00 pm ET
DRI Healthcare Trust Declares Special Distributions
TORONTO, Dec. 20, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), today announced that, its Board of Trustees has declared a special cash distribution in the amount of US$0.2662 per trust unit. The special cash distribution will be made payable to unitholders of record at the close of business on December 31, 2023, and paid to such unitholders on January 19, 2024. This special cash distribution is in addition to the quarterly cash distribution declared on November 13, 2023 of US$0.075 per trust unit.
Nov 13, 2023 04:00 pm ET
DRI Healthcare Trust Reports Third Quarter 2023 Results
– 36% royalty income growth over prior year period highlights successful portfolio growth strategy –
Oct 31, 2023 07:48 am ET
DRI Healthcare Trust Announces Upsized US$500 Million Credit Facilities
– Significantly enhances deployment capacity without increasing leverage parameters –
Oct 24, 2023 10:30 am ET
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 14, 2023
TORONTO, Oct. 24, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its third quarter 2023 financial results on Tuesday, November 14, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Monday, November 13, 2023, after market close.
Sep 20, 2023 12:11 pm ET
DRI Healthcare Trust Closes C$104 Million Bought Deal Public Offering Including Full Exercise of Over-Allotment Option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Sep 13, 2023 08:08 am ET
Canadian Investment Regulatory Organization Trade Resumption - DHT.UN
TORONTO, Sept. 13, 2023 /CNW/ - Trading resumes in:
Sep 12, 2023 03:43 pm ET
DRI Healthcare Trust Announces C$90 Million Bought Deal Public Offering of Units
DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters led by...
Sep 12, 2023 03:25 pm ET
Canadian Investment Regulatory Organization Trading Halt - DHT.UN
TORONTO, Sept. 12, 2023 /CNW/ - The following issues have been halted by CIRO:
Aug 14, 2023 05:00 pm ET
DRI Healthcare Trust Reports Second Quarter 2023 Results
– Continued strong portfolio performance with 16% royalty income growth over prior year period –
Aug 14, 2023 08:38 am ET
Canadian Investment Regulatory Organization Trade Resumption - DHT.UN
TORONTO, Aug. 14, 2023 /CNW/ - Trading resumes in:
Aug 14, 2023 08:36 am ET
Canadian Investment Regulatory Organization Trading Halt - DHT.UN
TORONTO, Aug. 14, 2023 /CNW/ - The following issues have been halted by CIRO:
Aug 14, 2023 08:30 am ET
Jul 25, 2023 10:00 am ET
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, July 25, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust intends to participate in the following investor conferences in 2023:
Jul 25, 2023 07:00 am ET
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 15, 2023
TORONTO, July 25, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its second quarter 2023 financial results on Tuesday, August 15, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Monday, August 14, 2023, after market close.
Jul 19, 2023 08:39 am ET
DRI Healthcare Trust Completes C$98 Million Bought Deal Public Offering of Units
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Jul 13, 2023 07:58 am ET
Canadian Investment Regulatory Organization Trade Resumption - DHT.UN
TORONTO, July 13, 2023 /CNW/ - Trading resumes in:
Jul 12, 2023 04:23 pm ET
DRI Healthcare Trust Announces C$85 Million Bought Deal Public Offering of Units
DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters led by CIBC...
Jul 12, 2023 04:18 pm ET
Canadian Investment Regulatory Organization Trading Halt - DHT.UN
TORONTO, July 12, 2023 /CNW/ - The following issues have been halted by CIRO:
Jul 07, 2023 01:19 pm ET
Canadian Investment Regulatory Organization Trade Resumption - DHT.UN
TORONTO, July 7, 2023 /CNW/ - Trading resumes in:
Jul 07, 2023 01:08 pm ET
Jul 07, 2023 12:43 pm ET
Canadian Investment Regulatory Organization Trading Halt - DHT.UN
TORONTO, July 7, 2023 /CNW/ - The following issues have been halted by CIRO:
Jun 30, 2023 05:00 am ET
Jun 26, 2023 05:00 pm ET
DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp.
– Provides additional deployment capacity in pursuing attractive deals in high-quality pipeline –
May 12, 2023 12:53 pm ET
DRI Healthcare Trust Announces Voting Results of AGM
TORONTO, May 12, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 12, 2023. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 29, 2023 were elected to serve as trustees for the ensuing year, and Deloitte LLP was reappointed as auditors of the Trust.
May 11, 2023 06:48 pm ET
DRI Healthcare Trust Reports First Quarter 2023 Results
– Robust royalty transaction activity showcases ability to execute on attractive deals –
May 10, 2023 01:00 pm ET
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, May 10, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust intends to participate in the following investor conferences in spring 2023:
Apr 27, 2023 11:00 am ET
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023
TORONTO, April 27, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that it will hold a conference call to discuss its first quarter financial results on Friday, May 12, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Thursday, May 11, 2023, after market close.
Apr 27, 2023 07:00 am ET
DRI Healthcare Trust Announces Sale of its TZIELD™ Royalty Interest to Sanofi for US$210 Million and Announces a US$20 Million Special Cash Distribution to Unitholders
– Transaction will allow DHT to redeploy capital into new deals generating compounding returns for unitholders –
Mar 08, 2023 04:30 pm ET
Mar 01, 2023 04:00 pm ET
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results
– 2022 deployment of US$281 million continues to validate growth strategy –
Feb 16, 2023 06:00 am ET
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023
TORONTO, Feb. 16, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that it will hold a conference call to discuss its fourth quarter and full year 2022 financial results on Thursday, March 2, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Wednesday, March 1, 2023, after market close.
Feb 08, 2023 07:29 am ET
DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target
Provides additional capital to fund biopharmaceutical research, driving value for DRI's unitholders and partners
Dec 21, 2022 04:00 pm ET
DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid
TORONTO, Dec. 21, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that, in accordance with the requirement for the Trust to distribute all of its taxable income for the year, the Board of Trustees has declared a special unit distribution of US$0.1655 per unit, which will be made payable to unitholders of record at the close of business on December 31, 2022 and paid to such unitholders on January 20, 2023.
Nov 28, 2022 06:30 am ET
Nov 07, 2022 04:00 pm ET
DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees
- Adds extensive expertise in corporate governance, strategy and ESG -
Nov 07, 2022 04:00 pm ET
DRI Healthcare Trust Reports Third Quarter 2022 Results
- Transactions for Empaveli, Zejula and Omidria royalties mark significant progress -
Oct 25, 2022 10:30 am ET
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022
TORONTO, Oct. 25, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its third quarter 2022 financial results on Tuesday, November 8, 2022, at 8:00 a.m. ET. The Trust will report its financial results on Monday, November 7, 2022, after market close.
Oct 03, 2022 07:05 am ET
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Omidria® for Intracameral Use During Cataract Surgery or Intraocular Lens Replacement
– Transaction adds a well-established ophthalmology product that generates substantial near-term cash flows, with long-term structural growth anticipated –
Oct 03, 2022 07:00 am ET
DRI Healthcare Trust Provides Update on Natpara Royalty
TORONTO, Oct. 3, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that, based on its ongoing review of its royalty entitlement on Natpara (the "Natpara Royalty"), DRI has concluded that the issues that led to the 2019 recall of Natpara in the United States are likely to remain unresolved for the foreseeable future, while royalties on European and Rest of World sales are expected to continue in the near term. There have been no commercial sales of Natpara in the United States since the product's recall in 2019.
Aug 04, 2022 01:06 pm ET
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, Aug. 4, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust will participate in the following investor conferences in August and September:
Jul 21, 2022 10:30 am ET
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022
TORONTO, July 21, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its second quarter 2022 financial results on Thursday, August 4, 2022, at 8:30 a.m. ET. The Trust will report its financial results on Wednesday, August 3, 2022, after market close.
Jul 21, 2022 07:30 am ET
May 11, 2022 05:07 pm ET
DRI Healthcare Trust Announces Voting Results of AGM
TORONTO, May 11, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 11, 2022. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 25, 2022 were elected to serve as trustees for the ensuing year, and Deloitte LLP was reappointed as auditors of the Trust.
May 10, 2022 05:00 pm ET
DRI Healthcare Trust Reports First Quarter 2022 Results
- Continued strong performance of existing assets and financial results -
Apr 27, 2022 11:00 am ET
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
TORONTO, April 27, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust will participate in the following investor conferences in the month of May:
Apr 27, 2022 10:30 am ET
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022
TORONTO, April 27, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at 8:00 a.m. ET. The Trust will report its financial results on Tuesday, May 10, 2022, after market close.
Apr 20, 2022 08:40 am ET
DRI Healthcare Trust Announces Upsized Credit Facility
TORONTO, April 20, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the "Amended Agreement") with a syndicate of banks regarding US$350 million of credit facilities (the "Facilities"). The Amended Agreement increases the capacity of the credit facilities announced on October 22, 2021, through a new tranche consisting of a delayed draw term loan of US$150 million. The Facilities have a maturity date of October 22, 2024, and are secured by all of the asse
Mar 07, 2022 04:00 pm ET
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results
- Announced growth-oriented and accretive transactions of up to $186 million -
Mar 07, 2022 04:00 pm ET
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results
- Announced growth-oriented and accretive transactions of up to $186 million -
Mar 01, 2022 06:00 am ET
DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)
TORONTO, March 1, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI") today announced that it has been notified by CTI BioPharma Corp. ("CTI") that the U.S. Food and Drug Administration ("FDA") has approved VONJO (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with platelets below 50 x 109/L. Myelofibrosis is a bone marrow cancer that results in formation of fibrous scar tissue and can lead to thrombocytopenia and anemia, weakness, fatigue and enlarged spleen
Feb 22, 2022 09:30 am ET
DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022
TORONTO, Feb. 22, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its fourth quarter and full-year 2021 financial results on Tuesday, March 8, 2022, at 8:30 a.m. ET. The Trust will report its financial results on Monday, March 7, 2022, after market close.
Dec 22, 2021 04:00 pm ET
DRI Healthcare Trust Declares Special Distributions
TORONTO, Dec. 22, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit. The special cash distribution will be made payable to unitholders of record at the close of business on December 31, 2021 and paid to such unitholders on January 20, 2022. This special cash distribution is in addition to the quarterly cash distribution declared on November 8, 2021 of US$0.075 per trust unit.
Nov 30, 2021 04:40 pm ET
DRI Healthcare Trust Comments on Extension of Review Period for pacritinib
TORONTO, Nov. 30, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application for pacritinib for the treatment of adult Myelofibrosis patients with severe thrombocytopenia. According to CTI, the PDUFA date has been extended by three months to February 28, 2022. Approval of pacritinib by the FDA is a condition to the acquisition by DRI of a tiered royalty on pacritinib, as announced on August
Nov 08, 2021 04:00 pm ET
Oct 25, 2021 10:30 am ET
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021
TORONTO, Oct. 25, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its 2021 third quarter financial results on Tuesday, November 9, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Monday, November 8, 2021, after market close.
Oct 22, 2021 07:30 am ET
DRI Healthcare Trust Announces US$200 Million Credit Facility
TORONTO, Oct. 22, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that a subsidiary of the Trust has entered into a credit agreement with a syndicate of banks regarding US$200 million of revolving credit facilities ("the Facilities"). An initial draw on the Facilities will be used to fully retire the existing senior secured notes issued by a subsidiary of the Trust, with future draws expected to be used to fund future acquisitions of royalty assets. The Facilities have a three-year term and are secured by all of the assets of the Trust and
Sep 30, 2021 05:00 pm ET
DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid
TORONTO, Sept. 30, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today the acceptance by the Toronto Stock Exchange (the "TSX") of the Trust's Notice of Intention to make a normal course issuer bid (the "NCIB"). Pursuant to the NCIB, the Trust proposes to purchase, from time to time, if considered advisable, up to an aggregate of 1,500,000 of its trust units (the "Units"), being approximately 3.7% of its 40,107,407 issued and outstanding trust units as of September 29, 2021, through the facilities of the TSX and/or through various eligible alte
Sep 30, 2021 09:39 am ET
IIROC Trade Resumption - DHT.UN
TORONTO, Sept. 30, 2021 /CNW/ - Trading resumes in:
Sep 30, 2021 09:31 am ET
IIROC Trading Halt - DHT.UN
TORONTO, Sept. 30, 2021 /CNW/ - The following issues have been halted by IIROC:
Sep 30, 2021 09:23 am ET
DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®
- Oracea® is the only branded oral prescription medication indicated for papulopustular rosacea -
Aug 25, 2021 08:00 am ET
DRI Healthcare Trust to Host Conference Call to Discuss Transaction Announcement
Conference call to be held Wednesday, August 25, 2021 at 1:30 pm ETTORONTO
Aug 25, 2021 07:30 am ET
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
–  Transaction to Fund Launch and Commercialization of Pacritinib in the United States This Year Pending FDA Approval, and Future Commercialization  –
Aug 25, 2021 07:00 am ET
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
SEATTLE and TORONTO, Aug. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) (CTI) and DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (DRI) today announced transactions totaling up to $135 million in funding for CTI, with $50 million in secured debt to be funded at closing and $60 million to purchase a tiered royalty on sales of pacrinitib upon product approval of pacrinitib by the U.S. Food and Drug Administration (FDA). The proceeds of the transactions will be used by CTI to fund the commercialization of pacritinib for the treatment of myelofibrosis patients with severe thrombocy
Aug 05, 2021 05:00 pm ET
DRI Healthcare Trust Reports Second Quarter 2021 Results
- Quarter highlighted by strong performance from existing pharmaceutical products portfolio -
Jul 26, 2021 10:30 am ET
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 6, 2021
TORONTO, July 26, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call to discuss its 2021 second quarter financial results on Friday, August 6, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Thursday, August 5, 2021, after market close.
May 10, 2021 07:00 am ET
DRI Healthcare Trust Reports First Quarter 2021 Results
- With IPO complete, Trust is focused on executing its business plan -
Apr 27, 2021 10:30 am ET
Notice of DRI Healthcare Trust's 2021 First Quarter Financial Results Earnings Call and Webcast
TORONTO, April 27, 2021 /CNW/ - DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (the "Trust") will release its 2021 first quarter financial results prior to market open on Monday, May 10, 2021. Management will host a conference call to review the financial results at 8:30 a.m. ET the same morning.
Mar 23, 2021 04:00 pm ET
DRI Healthcare Trust Declares Distribution
TORONTO, ON, March 23, 2021 /CNW/ - The board of trustees of DRI Healthcare Trust (the "Trust") (TSX: DHT.U) (TSX: DHT.UN) has approved the payment of a distribution of US$0.0167 per trust unit. The distribution will be paid on April 20, 2021 to unitholders of record at the close of business on March 31, 2021. The distribution is for the period from the closing of the initial public offering of the Trust on February 19, 2021 to March 31, 2021.
Feb 23, 2021 10:26 am ET
DRI Healthcare Trust Virtually Opens the Market
TORONTO, Feb. 23, 2021 /CNW/ - Behzad Khosrowshahi, Chief Executive Officer, DRI Healthcare Trust (the "Trust") (TSX: DHT.U) (TSX: DHT.UN), and his team joined Dani Lipkin, Director, Global Business Development, TMX Group, to celebrate the Trust's new listing on Toronto Stock Exchange and open the market.
Feb 19, 2021 07:34 am ET
DRI Healthcare Trust Completes Initial Public Offering
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/
Feb 11, 2021 08:06 am ET
IIROC Trade Resumption - DHT.UN
TORONTO, Feb. 11, 2021 /CNW/ - Trading resumes in:
Feb 11, 2021 07:00 am ET
IIROC Trading Halt - DHT.UN
TORONTO, Feb. 11, 2021 /CNW/ - The following issues have been halted by IIROC: